Fairfax Financial Holdings’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

Fairfax Financial Holdings’s Portfolio PRVB Stock Details PRVB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-277,000	Closed	-$6.67M	–	72
2023 Q1	$6.67M	Buy	+277,000	New	+$3.48M	0.38%	22

Other funds holding PRVB

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Fairfax Financial Holdings's PRVB Position: Q2 2023 in Review

Fairfax Financial Holdings sold out of Provention Bio, Inc. Common Stock (PRVB) in Q2 2023, closing a stake of 277,000 shares — an estimated $6.67M sold.

Fairfax Financial Holdings first reported a position in PRVB in Q1 2023 and held it in 1 quarter. The position peaked at $6.67M in Q1 2023. 1 fund tracked by Wall St. Rank holds PRVB as of Q2 2023.

Fairfax Financial Holdings reported no remaining Provention Bio, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Fairfax Financial Holdings sold 277,000 Provention Bio, Inc. Common Stock shares in Q2 2023, an estimated $6.67M.
Fairfax Financial Holdings first reported a position in Provention Bio, Inc. Common Stock in Q1 2023 and held it in 1 quarter.
Fairfax Financial Holdings's Provention Bio, Inc. Common Stock position peaked at $6.67M in Q1 2023.
1 fund tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q2 2023.

Based on Fairfax Financial Holdings's 13F filing for Q2 2023, filed 14 Aug 2023.